Home > Browse Issues > Vol.27 No.6
The Development in Thymosin α1
Gui-Xiang Qin, Xing-Guo Gong*, Jing Ji
College of Life Sciences, Zhejiang University, Hangzhou 310027, China
Abstract: Thymosin α1 (Tα1) was an immune active peptide in vivo. It was used in the treatment of hepatitis B， hepatitis C， tumors and immune-deficiency syndrome. It was generally considered as an important biological response modifier， though the mechanisms of Tα1 was still not well mastered. Here， we reviewed the distribution， mechanism model of functions， and clinical application of Tα1， and summarized its recent development in biosynthesis.
CN
EN